A citation-based method for searching scientific literature

Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan, Hanno B Richards, Shephard Mpofu. N Engl J Med 2015
Times Cited: 486







List of co-cited articles
871 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
4

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
T Kobayashi, S Okamoto, T Hisamatsu, N Kamada, H Chinen, R Saito, M T Kitazume, A Nakazawa, A Sugita, K Koganei,[...]. Gut 2008
390
4

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Stephen K Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, Nicole Cichanowitz, Qing Li,[...]. Lancet 2017
288
4

Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Tony J Kenna, Stuart I Davidson, Ran Duan, Linda A Bradbury, Janelle McFarlane, Malcolm Smith, Helen Weedon, Shayna Street, Ranjeny Thomas, Gethin P Thomas,[...]. Arthritis Rheum 2012
183
4

Transforming growth factor-beta induces development of the T(H)17 lineage.
Paul R Mangan, Laurie E Harrington, Darrell B O'Quinn, Whitney S Helms, Daniel C Bullard, Charles O Elson, Robin D Hatton, Sharon M Wahl, Trenton R Schoeb, Casey T Weaver. Nature 2006
4

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
Wolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, Andrew M Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H Gold, Patrick Durez,[...]. Sci Transl Med 2010
660
4

IL-17 Signaling: The Yin and the Yang.
Nilesh Amatya, Abhishek V Garg, Sarah L Gaffen. Trends Immunol 2017
295
4

IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.
James G Krueger, Keith A Wharton, Thomas Schlitt, Maria Suprun, Rebecca I Torene, Xiaoyu Jiang, Claire Q Wang, Judilyn Fuentes-Duculan, Nicole Hartmann, Thomas Peters,[...]. J Allergy Clin Immunol 2019
53
7

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.
Alexander R Moschen, Herbert Tilg, Tim Raine. Nat Rev Gastroenterol Hepatol 2019
172
4

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.
Heather R Conti, Fang Shen, Namrata Nayyar, Eileen Stocum, Jianing N Sun, Matthew J Lindemann, Allen W Ho, Justine Hoda Hai, Jeffrey J Yu, Ji Won Jung,[...]. J Exp Med 2009
704
4

Increased expression of interleukin 17 in inflammatory bowel disease.
S Fujino, A Andoh, S Bamba, A Ogawa, K Hata, Y Araki, T Bamba, Y Fujiyama. Gut 2003
4

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
Ana-Maria Orbai, Maarten de Wit, Philip Mease, Judy A Shea, Laure Gossec, Ying Ying Leung, William Tillett, Musaab Elmamoun, Kristina Callis Duffin, Willemina Campbell,[...]. Ann Rheum Dis 2017
132
4

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
Dafna D Gladman, Ana-Maria Orbai, Uta Klitz, James Cheng-Chung Wei, Gaia Gallo, Julie Birt, Suchitrita Rathmann, David Shrom, Helena Marzo-Ortega. Arthritis Res Ther 2019
23
17

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Philip J Mease, Jacqueline B Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T Ritchlin, Chitra Karki, Jeffrey D Greenberg. J Rheumatol 2018
46
8

Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study.
K Reich, L Puig, J C Szepietowski, C Paul, J P Lacour, A Tsianakas, C Sieder, M Rissler, E Pournara, R Orsenigo. Br J Dermatol 2020
25
16

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
Alice Gottlieb, John Sullivan, Martijn van Doorn, Alexey Kubanov, Ruquan You, Anne Parneix, Sophie Hugot, Marina Milutinovic. J Am Acad Dermatol 2017
77
5

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.
Bente Glintborg, Mikkel Østergaard, Lene Dreyer, Niels Steen Krogh, Ulrik Tarp, Michael Sejer Hansen, Signe Rifbjerg-Madsen, Tove Lorenzen, Merete Lund Hetland. Arthritis Rheum 2011
172
4

Psoriatic arthritis.
J M Moll, V Wright. Semin Arthritis Rheum 1973
788
4

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register.
Amr A Saad, Darren M Ashcroft, Kath D Watson, Kimme L Hyrich, Peter R Noyce, Deborah P M Symmons. Arthritis Res Ther 2009
151
4

Switching biologics in the treatment of psoriatic arthritis.
Joseph F Merola, Benjamin Lockshin, Elinor A Mody. Semin Arthritis Rheum 2017
49
8

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
Désirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, Walter P Maksymowych, Vira Tseluyko, Oleg Nadashkevich, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Robin Besuyen,[...]. Lancet 2018
126
4

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Andrea Chiricozzi, Emma Guttman-Yassky, Mayte Suárez-Fariñas, Kristine E Nograles, Suyan Tian, Irma Cardinale, Sergio Chimenti, James G Krueger. J Invest Dermatol 2011
409
4

Targeting IL-17 and TH17 cells in chronic inflammation.
Pierre Miossec, Jay K Kolls. Nat Rev Drug Discov 2012
818
4

Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.
Shandor Erdes, Evgeny Nasonov, Elena Kunder, Andrey Pristrom, Nikolay Soroka, Pavel Shesternya, Tatiana Dubinina, Svetlana Smakotina, Tatiana Raskina, Diana Krechikova,[...]. Clin Exp Rheumatol 2020
14
28

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.
Eleni Kampylafka, Isabelle d'Oliveira, Christina Linz, Veronika Lerchen, Fabian Stemmler, David Simon, Matthias Englbrecht, Michael Sticherling, Jürgen Rech, Arnd Kleyer,[...]. Arthritis Res Ther 2018
36
11

Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial.
C Paul, K Reich, A B Gottlieb, U Mrowietz, S Philipp, J Nakayama, E Harfst, A Guettner, C Papavassilis. J Eur Acad Dermatol Venereol 2014
53
7

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
Eleni Kampylafka, David Simon, Isabelle d'Oliveira, Christina Linz, Veronika Lerchen, Matthias Englbrecht, Juergen Rech, Arnd Kleyer, Michael Sticherling, Georg Schett,[...]. Arthritis Res Ther 2019
35
11

Safety of secukinumab in the treatment of psoriasis.
Andrew Blauvelt. Expert Opin Drug Saf 2016
67
5

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.
Iain B McInnes, Philip J Mease, Georg Schett, Bruce Kirkham, Vibeke Strand, Nicole Williams, Todd Fox, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi. Arthritis Res Ther 2018
16
25

Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results.
M Augustin, E Dauden, U Mrowietz, M P Konstantinou, S Gerdes, K Kingo, J C Szepietowski, J L Perrot, A Cuccia, M Rissler,[...]. J Eur Acad Dermatol Venereol 2021
10
40

Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.
Jennifer Belasco, James S Louie, Nicholas Gulati, Nathan Wei, Kristine Nograles, Judilyn Fuentes-Duculan, Hiroshi Mitsui, Mayte Suárez-Fariñas, James G Krueger. Arthritis Rheumatol 2015
74
5

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.
Laura C Coates, Laure Gossec, Sofia Ramiro, Philip Mease, Désirée van der Heijde, Josef S Smolen, Christopher Ritchlin, Arthur Kavanaugh. Rheumatology (Oxford) 2017
36
11

Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis.
Iain B McInnes, Peter Nash, Christopher Ritchlin, Ernest H Choy, Steve Kanters, Howard Thom, Kunal Gandhi, Luminita Pricop, Steffen M Jugl. J Comp Eff Res 2018
23
17

Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study.
Karel Pavelka, Alan J Kivitz, Eva Dokoupilova, Ricardo Blanco, Marco Maradiaga, Hasan Tahir, Yi Wang, Brian O Porter, Anna Stefanska, Hanno B Richards,[...]. ACR Open Rheumatol 2020
14
28

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Richard H Duerr, Kent D Taylor, Steven R Brant, John D Rioux, Mark S Silverberg, Mark J Daly, A Hillary Steinhart, Clara Abraham, Miguel Regueiro, Anne Griffiths,[...]. Science 2006
4

Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice.
Annika Reinhardt, Tetyana Yevsa, Tim Worbs, Stefan Lienenklaus, Inga Sandrock, Linda Oberdörfer, Thomas Korn, Siegfried Weiss, Reinhold Förster, Immo Prinz. Arthritis Rheumatol 2016
128
4


Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.
Philip J Mease, Dafna D Gladman, Kim A Papp, Majed M Khraishi, Diamant Thaçi, Frank Behrens, Robert Northington, Joanne Fuiman, Eustratios Bananis, Robert Boggs,[...]. J Am Acad Dermatol 2013
276
4

IL-17 receptor and its functional significance in psoriatic arthritis.
Siba P Raychaudhuri, Smriti K Raychaudhuri, Mark C Genovese. Mol Cell Biochem 2012
141
4

Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.
Kim A Papp, Joseph F Merola, Alice B Gottlieb, Christopher E M Griffiths, Nancy Cross, Luke Peterson, Christopher Cioffi, Andrew Blauvelt. J Am Acad Dermatol 2018
103
4

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).
Arthur Kavanaugh, Lluis Puig, Alice B Gottlieb, Christopher Ritchlin, Yin You, Shu Li, Michael Song, Bruce Randazzo, Proton Rahman, Iain B McInnes. Ann Rheum Dis 2016
99
4

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.
Asta Baranauskaite, Helena Raffayová, N V Kungurov, Anna Kubanova, Algirdas Venalis, Laszlo Helmle, Shankar Srinivasan, Evgeny Nasonov, Nathan Vastesaeger. Ann Rheum Dis 2012
126
4

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial.
Arthur Kavanaugh, Lluís Puig, Alice B Gottlieb, Christopher Ritchlin, Shu Li, Yuhua Wang, Alan M Mendelsohn, Michael Song, Yaowei Zhu, Proton Rahman,[...]. Arthritis Care Res (Hoboken) 2015
65
6

Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Arthur Kavanaugh, Désirée van der Heijde, Iain B McInnes, Philip Mease, Gerald G Krueger, Dafna D Gladman, Juan Gómez-Reino, Kim Papp, Anna Baratelle, Weichun Xu,[...]. Arthritis Rheum 2012
157
4


Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.
Xenofon Baraliakos, Alan J Kivitz, Atul A Deodhar, Jürgen Braun, James C Wei, Eumorphia Maria Delicha, Zsolt Talloczy, Brian Porter. Clin Exp Rheumatol 2018
58
6

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
Alice Gottlieb, Alan Menter, Alan Mendelsohn, Yaung-Kaung Shen, Shu Li, Cynthia Guzzo, Scott Fretzin, Rod Kunynetz, Arthur Kavanaugh. Lancet 2009
431
4

Oral apremilast in the treatment of active psoriatic arthritis: results of a multicenter, randomized, double-blind, placebo-controlled study.
Georg Schett, Jurgen Wollenhaupt, Kim Papp, Rik Joos, Jude F Rodrigues, Adele R Vessey, ChiaChi Hu, Randall Stevens, Kurt L de Vlam. Arthritis Rheum 2012
147
4

IL-17: prototype member of an emerging cytokine family.
Sudeepta Aggarwal, Austin L Gurney. J Leukoc Biol 2002
419
4

Effects of Interleukin 17 on the cardiovascular system.
Marie Robert, Pierre Miossec. Autoimmun Rev 2017
65
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.